Christine Chambers - 31 May 2024 Form 4 Insider Report for PETMED EXPRESS INC (PETS)

Role
CFO
Signature
/s/ Christine Chambers
Issuer symbol
PETS
Transactions as of
31 May 2024
Transactions value $
$0
Form type
4
Filing time
04 Jun 2024, 14:00:16 UTC
Previous filing
20 May 2024
Next filing
28 Oct 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PETS Common Stock Disposed to Issuer $0 -41,342 -39% $0 65,146 31 May 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PETS Performance Share Units Disposed to Issuer $0 -8,000 -100% $0* 0 31 May 2024 Common Stock 8,000 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the forfeiture as a result of the Transition and Separation Agreement dated May 31, 2024 between the Company and the reporting person ("Agreement") of (i) 3,917 restricted stock units granted pursuant to the PetMed Express, Inc.'s 2022 Employee Equity Compensation Plan ("2022 Plan") on June 15, 2023, and (ii) 37,425 restricted stock units granted pursuant to the 2022 Plan on May 16, 2024.
F2 Performance Share Units ("PSUs") granted pursuant to the Plan. Each PSU represents a contingent right to receive one share of the Company's Common Stock if predetermined levels of the Company's total shareholder return relative to the S&P 600 Specialty Retail Index are achieved over a three-year performance period ending on March 31, 2026.
F3 Represents the forfeiture as a result of the Agreement of 8,000 performance stock units granted pursuant to the 2022 Plan on June 15, 2023.